To date, the exact mechanism through which TMEM106B variants are linked to hypomyelinating leukodystrophy and FTD risks remains to be fully elucidated, although studies have suggested that it involves TMEM106B-mediated lysosomal regulation/transport [188]. The gene discussed is TMEM106B; the disease is leukodystrophy.